Novo and Boston Scientific-backed medical device maker Minerva has filed to raise up to $100m in an IPO on the Nasdaq Global Stock Market.
US-based medical device maker Minerva Surgical filed on Monday for an initial public offering that could allow pharmaceutical firm Novo and medical equipment manufacturer Boston Scientific Corporation to exit.
The company has set a $100m placeholder target for the IPO, which is set to take place on the Nasdaq Global Stock Market. JP Morgan, Piper Sandler, UBS Investment Bank and SVB Leerink are the underwriters for the offering.
Founded in 2008, Minerva is focused on the development of a…
